help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on May 25, 2006, doi:10.1164/rccm.200512-1886OC

Am. J. Respir. Crit. Care Med., Volume 174, Number 4, August 2006, 461-470

A more recent version of this article appeared on August 15, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200512-1886OCv1
174/4/461    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mikols, C. L
Right arrow Articles by Walter, M. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mikols, C. L
Right arrow Articles by Walter, M. J

Submitted on December 9, 2005
Accepted on May 19, 2006

IL-12 p80 is an Innate Epithelial Cell Effector that Mediates Chronic Allograft Dysfunction

Cassandra L Mikols1, Le Yan1, Jin Y Norris1, Tonya D Russell1, Anthony P Khalifah1, Ramsey R Hachem1, Murali M Chakinala1, Roger D Yusen1, Mario Castro1, Elbert Kuo2, G. Alexander Patterson2, Thalachallour Mohanakumar2, Elbert P Trulock1, and Michael J Walter1*

1 Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, Missouri, USA, 2 Division of Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA

* To whom correspondence should be addressed. E-mail: mwalter{at}im.wustl.edu.

Rationale: Bronchiolitis obliterans syndrome (BOS) is the leading cause of chronic lung allograft dysfunction. We have demonstrated respiratory viral infection is a BOS risk factor and viral-dependent injury induces expression of innate airway epithelial genes belonging to the IL-12 family. Thus, we hypothesized that epithelial cell IL-12 family members could mediate lung allograft dysfunction. Objectives: We utilized mouse and human allograft specimens to evaluate the role of epithelial cell IL-12 family members in allograft dysfunction associated with and without viral infection. Methods: Murine and human IL-12 family members were characterized and manipulated in allografts and then correlated with epithelial cell injury, immune cell accumulation, and collagen deposition. Results: In a mouse model of lung transplantation, concurrent viral infection and allogeneic transplantation increased epithelial injury and this was followed by an exaggerated accumulation of macrophages and collagen deposition. This viral-driven allograft dysfunction was associated with an epithelial innate response manifested by a synergistic increase in the production of the macrophage chemoattractant IL-12 p80 (p80), but not IL-12 or IL-23. Blockade or overexpression of donor epithelial p80 resulted in a corresponding abrogation or enhancement in macrophage accumulation and allograft dysfunction. We extended these findings to human recipients with viral infection and transplant bronchitis and again observed excessive epithelial p80 expression that correlated with an increased macrophage accumulation. Conclusions: These experiments support a role for an enhanced epithelial innate response as a central process in allograft dysfunction and identify the macrophage chemoattractant p80 as an innate epithelial effector of disease progression.


Key words: Lung transplantation, virus, innate immunity, macrophage, graft rejection




This article has been cited by other articles:


Home page
JEMHome page
X. Yuan, J. Paez-Cortez, I. Schmitt-Knosalla, F. D'Addio, B. Mfarrej, M. Donnarumma, A. Habicht, M. R. Clarkson, J. Iacomini, L. H. Glimcher, et al.
A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy
J. Exp. Med., December 1, 2008; (2008) jem.20081937.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
L. B. Ware
Clinical Year in Review III: Asthma, Lung Transplantation, Cystic Fibrosis, Acute Respiratory Distress Syndrome
Proceedings of the ATS, September 15, 2007; 4(6): 489 - 493.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. A. Corris and J. D. Christie
Update in Transplantation 2006
Am. J. Respir. Crit. Care Med., March 1, 2007; 175(5): 432 - 435.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2006 American Thoracic Society
  ATS State of the Art 2009